Jonathan Norman
Director of Localization Services, YPrime
Amidst the excitement of SCOPE 2025, Applied Clinical Trials pulled in YPrime’s Director of Localization Services, Jonathan Norman, to discuss the significant impact of efficient eCOA localization on clinical trials.
Topic #1
Optimizing Localization to Accelerate Global Trials from Launch to Finish Line
Effective localization of eCOA instruments accelerates global trial launches by ensuring accurate data collection across diverse populations. Early identification of target countries and languages allows timely translation, maintaining data integrity without delaying study timelines.
Topic #2
Boosting Global Trial Speed, Compliance, and Patient Engagement Through Efficient Localization
A proactive approach to localization facilitates strategic decision-making and minimizes delays in trial timelines. It can accelerate global trials by improving patient trust and communication, enabling diverse recruitment, and allowing sponsors to prepare for varied regulatory requirements.